Crizanlizumab Pregnancy Outcomes Intensive Monitoring
NCT07554547
·
clinicaltrials.gov ↗
COMPLETED
Status
13
Enrollment
INDUSTRY
Sponsor class
Conditions
Sickle Cell Disease
Sponsor
Novartis Pharmaceuticals